Manufacturer copay assistance · Ruxience (Q5119) · Pfizer
Eligible… · Maximum benefit Up to $25,000/year in savings · Covers Ruxience drug copay only — does NOT cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Ruxience — the program's cap applies against the patient share CareCost calculates.
Yes — Pfizer Oncology Together Co-Pay Savings Program for Injectables (Ruxience) from Pfizer. Eligible commercially-insured patients may pay as little as $0 per treatment. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible commercially-insured patients may pay as little as $0 per treatment Maximum benefit: Up to $25,000/year in savings. Covers Ruxience drug copay only — does NOT cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.